Indication
Type 1 Diabetes With Diabetic Macular Edema
1 clinical trial
1 product
Product
MS-553Clinical trial
A Multicenter, Open-label, Dose Escalation Study Assessing the Safety and Treatment Effects of MS-553 in Diabetic Retinopathy Patients With Central Involved Macular EdemaStatus: Recruiting, Estimated PCD: 2023-12-31